Source: FinSMEs

Adapsyn Bioscience: Adapsyn Bioscience Completes Financing Round

Adapsyn Bioscience Inc., a Hamilton, On., Canada-based biotechnology company focused on the discovery and development of novel medicines derived from evolved small molecule natural products, completed a round of financing of undisclosed amount. Backers included Pfizer R&D Innovate and Genesys Capital. The company intends to use the funds for its internal drug development programs. Founded [...]

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Andrew Haigh's photo - President & CEO of Adapsyn

President & CEO

Andrew Haigh

CEO Approval Rating

90/100

Read more